|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
|
beta-adrenergic antagonist
An agent that binds to but does not activate beta-adrenergic receptors thereby blocking the actions of endogenous or exogenous beta-adrenergic agonists. beta-Adrenergic antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches and anxiety.
|
|
|
beta-adrenergic antagonist
An agent that binds to but does not activate beta-adrenergic receptors thereby blocking the actions of endogenous or exogenous beta-adrenergic agonists. beta-Adrenergic antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches and anxiety.
anti-arrhythmia drug
A drug used for the treatment or prevention of cardiac arrhythmias. Anti-arrhythmia drugs may affect the polarisation-repolarisation phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibres.
|
|
|
N-{4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}acetamide
|
|
(±)-practolol
|
ChEBI
|
1-(4-acetamidophenoxy)-3-isopropylamino-2-propanol
|
ChemIDplus
|
|
4'-(2-hydroxy-3-(isopropylamino)propoxy)acetanilide
|
ChemIDplus
|
|
N-(4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)phenyl)acetamide
|
ChemIDplus
|
10(2)